Drug recall
Methotrexate Injection, USP 50 mg/2 mL (25 mg/mL), 2 mL Single-dose Vial, packaged in 5 x 2 mL vials per…
FDA recall event 70936 · Class I · Mylan Institutional LLC
Key facts
| Event ID | 70936 |
|---|---|
| Recall numbers | D-1328-2015 |
| Recalling firm | Mylan Institutional LLC |
| Product type | Drugs |
| Products | Methotrexate Injection, USP 50 mg/2 mL (25 mg/mL), 2 mL Single-dose Vial, packaged in 5 x 2 mL vials per carton, Rx only, labeled as a) Distributed by Pfizer Labs, Division of Pfizer Inc., New York… |
| Classification | Class I |
| Status | Terminated |
| Voluntary or mandated | Firm Initiated |
| Reason for recall | Presence of Particulate Matter |
| Initiation date | Mar 18, 2015 |
| Report date | Aug 19, 2015 |
| Termination date | Jun 29, 2016 |
| City | Rockford |
| State | IL |
| Country | United States |
| FEI number | 3010547225 |
At a glance
- 1–9 Products in this recall
- None FDA inspections of this firm (FEI)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug and product recalls
FDA enforcement reports list recalls of drugs, biologics, foods and other FDA-regulated products, classified by the potential health hazard.
Source: U.S. Food and Drug Administration (FDA), Enforcement Reports · Source date: